Please use this identifier to cite or link to this item:
Title: Hepatitis a and e infection in international travellers.
Austin Authors: Torresi, Joseph ;Johnson, Douglas F
Affiliation: Infectious Diseases
Issue Date: 1-Jun-2011
Publication information: Current Infectious Disease Reports; 13(3): 248-55
Abstract: Hepatitis A is the most common vaccine-preventable infection in travellers. The incidence of hepatitis A for travellers ranges from 3.0 to 11.0 per 100,000 person-months and the case-fatality rate is as high as 2 per 100,000 in non-immune travellers. Hepatitis A vaccine is highly effective in preventing infection, significantly reducing the incidence of hepatitis A in travellers, and an important preventative intervention for the "last-minute" traveller. Hepatitis E virus is an important cause of enterically transmitted hepatitis in developing countries. The overall risk of hepatitis E in travellers visiting endemic countries is relatively low compared to hepatitis A. The majority of cases have been reported from the Indian subcontinent. The case fatality rate for hepatitis E is 1.2%, although this is substantially higher in pregnant women. A vaccine for hepatitis E is not available, and therefore travellers must be made aware of preventative measures to reduce their risk of infection.
DOI: 10.1007/s11908-011-0179-7
Journal: Current Infectious Disease Reports
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
21424252.pdf55.68 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Dec 7, 2023


checked on Dec 7, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.